Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands

Moraga I, Wernig G, Wilmes S, Gryshkova V, Richter CP, Hong WJ, Sinha R, Guo F, Fabionar H, Wehrman TS, Krutzik P, Demharter S, Plo I, Weissman IL, Minary P, Majeti R, Constantinescu SN, Piehler J, Garcia KC.
Source: Cell
Publication Date: (2015)
Issue: 160(6): 1196-208
Research Area:
Gene Expression
Basic Research
Cells used in publication:
High Five
Species: Trichopulsia ni (Cabbage Looper)
Tissue Origin:
Culture Media:
Most cell-surface receptors for cytokines and growth factors signal as dimers. In this article, the authors Show that syntehtic ligands called diabodies can change the Amplitude and nature of signal activation. They also describe, that non-agonistic diabosides counteract intracellular oncogenic signalling. For this purpose, they express EpoR diabodies and EpoR glycomutants using the baculovirus Expression System. Protein Expression is performed in High Five cells grown in InsectXpress. The resulting EpoR diabodies are used to perform crystallization, structure determination and refinement
Most cell-surface receptors for cytokines and growth factors signal as dimers, but it is unclear whether remodeling receptor dimer topology is a viable strategy to "tune" signaling output. We utilized diabodies (DA) as surrogate ligands in a prototypical dimeric receptor-ligand system, the cytokine Erythropoietin (EPO) and its receptor (EpoR), to dimerize EpoR ectodomains in non-native architectures. Diabody-induced signaling amplitudes varied from full to minimal agonism, and structures of these DA/EpoR complexes differed in EpoR dimer orientation and proximity. Diabodies also elicited biased or differential activation of signaling pathways and gene expression profiles compared to EPO. Non-signaling diabodies inhibited proliferation of erythroid precursors from patients with a myeloproliferative neoplasm due to a constitutively active JAK2V617F mutation. Thus, intracellular oncogenic mutations causing ligand-independent receptor activation can be counteracted by extracellular ligands that re-orient receptors into inactive dimer topologies. This approach has broad applications for tuning signaling output for many dimeric receptor systems.